Northwestern Mutual Wealth Management
FATE icon

Northwestern Mutual Wealth Management’s Fate Therapeutics FATE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-255
Closed -$421 – 3751
2024
Q4 		$421 Hold
255
– – ﹤0.01% 3401
2024
Q3 		$893 Hold
255
– – ﹤0.01% 3269
2024
Q2 		$836 Sell
255
-600
-70% -$2.63K ﹤0.01% 3233
2024
Q1 		$6.28K Buy
+855
New +$5.29K ﹤0.01% 2775
2022
Q3 		– Sell
-2
Closed – – 3193
2022
Q2 		$0 Buy
+2
New +$55 ﹤0.01% 3262

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Northwestern Mutual Wealth Management's FATE Position: Q1 2025 in Review

Northwestern Mutual Wealth Management sold out of Fate Therapeutics (FATE) in Q1 2025, closing a stake of 255 shares — an estimated $421 sold.

Northwestern Mutual Wealth Management first reported a position in FATE in Q2 2022 and held it in 5 quarters. The position peaked at $6.28K in Q1 2024. 132 funds tracked by Wall St. Rank hold FATE as of Q1 2025.

  • Northwestern Mutual Wealth Management reported no remaining Fate Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 255 Fate Therapeutics shares in Q1 2025, an estimated $421.
  • Northwestern Mutual Wealth Management first reported a position in Fate Therapeutics in Q2 2022 and held it in 5 quarters.
  • Northwestern Mutual Wealth Management's Fate Therapeutics position peaked at $6.28K in Q1 2024.
  • 132 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.